Clinical Trials Directory

Trials / Sponsors / Shanghai Jiaolian Drug Research and Development Co., Ltd

Shanghai Jiaolian Drug Research and Development Co., Ltd

Industry · 7 registered clinical trials — 6 currently recruiting.

StatusTrialPhaseStarted
RecruitingA Clinical Study of B007 in the Treatment of Primary Membranous Nephropathy.
Primary Membranous Nephropathy
Phase 2 / Phase 32024-07-30
RecruitingA Clinical Study of B001 Injection in the Treatment of Neuromyelitis Optica Spectrum Disorders(NMOSD)
Neuromyelitis Optica Spectrum Disorders
Phase 2 / Phase 32024-07-17
RecruitingA Clinical Study of B007 in the Treatment of Pemphigus.
Pemphigus
Phase 2 / Phase 32024-07-12
RecruitingA Study of B013 in Combination With Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer.
Platinum-resistant Recurrent Ovarian Cancer
Phase 22024-07-11
RecruitingA Clinical Study of B007 in the Treatment of Generalized Myasthenia Gravis.
Generalized Myasthenia Gravis
Phase 2 / Phase 32024-07-01
RecruitingA Phase I Clinical Study of Recombinant Humanized Anti-CD20(B-lymphocyte Antigen CD20) Monoclonal Antibody Sub
Primary Membranous Nephropathy
Phase 12023-03-02
CompletedStudy of B013 and Nab-Paclitaxel for Locally Advanced or Metastatic Triple Negative Breast Cancer
Triple Negative Breast Cancer (TNBC)
Phase 2 / Phase 32022-12-06